Effect of an increase in dose of istradefylline, an A2A receptor antagonist, in levodopa-treated patients with Parkinson's Disease (PD)

Autor: Hattori, N., Nomura, T., Salzman, P.M., Kitabayashi, H., Ishiuchi, M., Toyama, K., Ristuccia, R., Mori, A.
Zdroj: In Parkinsonism and Related Disorders October 2020 79 Supplement 1:e58-e58
Databáze: ScienceDirect